Growth hormone receptor targeting to lipid rafts requires extracellular subdomain 2

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 414-418

  Yang, Ning ^a   Jiang, Jing ^a   Deng, Luqin ^a   Waters, Michael J ^c   Wang, Xiangdong ^a   Frank, Stuart J ^a,b,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Determinant; Growth hormone receptor; Lipid raft

Indexed keywords

GROWTH HORMONE RECEPTOR; JANUS KINASE 2; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXTRACTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID RAFT; MUTANT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; HUMANS; JANUS KINASE 2; MEMBRANE MICRODOMAINS; MICE; PROTEIN STRUCTURE, TERTIARY; RABBITS; RECEPTORS, SOMATOTROPIN;

EID: 72949118879     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.072     Document Type: Article

References (41)

1. Frank S.J., and Messina J.L. Growth hormone receptor. In: Oppenheim J.J., and Feldman M. (Eds). Cytokine Reference On-line (2002), Academic Press, Harcourt, London, UK 1-21
2. Frank S.J., Gilliland G., Kraft A.S., and Arnold C.S. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology 135 (1994) 2228-2239
3. Frank S.J., Yi W., Zhao Y., Goldsmith J.F., Gilliland G., Jiang J., Sakai I., and Kraft A.S. Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. J. Biol. Chem. 270 (1995) 14776-14785
4. He K., Wang X., Jiang J., Guan R., Bernstein K.E., Sayeski P.P., and Frank S.J. Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling. Mol. Endocrinol. 17 (2003) 2211-2227
5. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.H., Ram P.A., Waxman D.J., and Davey H.W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94 (1997) 7239-7244
6. Woelfle J., Billiard J., and Rotwein P. Acute control of insulin-like growth factor-I gene transcription by growth hormone through STAT5b. J. Biol. Chem. 278 (2003) 22696-22702
7. Smit L.S., Meyer D.J., Billestrup N., Norstedt G., Schwartz J., and Carter-Su C. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of STATs 1, 3, and 5 by GH. Mol. Endocrinol. 10 (1996) 519-533
8. Wang X., Darus C.J., Xu B.C., and Kopchick J.J. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation. Mol. Endocrinol. 10 (1996) 1249-1260
9. Yi W., Kim S.O., Jiang J., Park S.H., Kraft A.S., Waxman D.J., and Frank S.J. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Mol. Endocrinol. 10 (1996) 1425-1443
10. Moller C., Hansson A., Enberg B., Lobie P.E., and Norstedt G. Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA. J. Biol. Chem. 267 (1992) 23403-23408
11. Campbell G.S., Pang L., Miyasaka T., Saltiel A.R., and Carter-Su C. Stimulation by growth hormone of map kinase activity in 3T3-F442A fibroblasts. J. Biol. Chem. 267 (1992) 6074-6080
12. Yang N., Huang Y., Jiang J., and Frank S.J. Caveolar and lipid raft localization of GH receptor and its signaling elements: impact on GH signaling. J. Biol. Chem. 279 (2004) 20898-20905
13. Galbiati F., Razani B., and Lisanti M.P. Emerging themes in lipid rafts and caveolae. Cell 106 (2001) 403-411
14. Brown D.A. Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology (Bethesda) 21 (2006) 430-439
15. Zhang Y., Guan R., Jiang J., Kopchick J.J., Black R.A., Baumann G., and Frank S.J. Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis. J. Biol. Chem. 276 (2001) 24565-24573
16. Jiang J., Liang L., Kim S.O., Zhang Y., Mandler R., and Frank S.J. Growth hormone-dependent tyrosine phosphorylation of a GH receptor-associated high molecular weight protein immunologically related to JAK2. Biochem. Biophys. Res. Commun. 253 (1998) 774-779
17. Wang X., He K., Gerhart M., Huang Y., Jiang J., Paxton R.J., Yang S., Lu C., Menon R.K., Black R.A., Baumann G., and Frank S.J. Metalloprotease-mediated GH receptor proteolysis and GHBP shedding. Determination of extracellular domain stem region cleavage site. J. Biol. Chem. 277 (2002) 50510-50519
18. Yang N., Wang X., Jiang J., and Frank S.J. Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation. Mol. Endocrinol. 21 (2007) 1642-1655
19. cowan J.W., Wang X., Guan R., He K., Jiang J., Baumann G., Black R.A., Wolfe M.S., and Frank S.J. Growth hormone receptor is a target for presenilin-dependent gamma-secretase cleavage. J. Biol. Chem. 280 (2005) 19331-19342
20. Kohlhuber F., Rogers N.C., Watling D., Feng J., Guschin D., Briscoe J., Witthuhn B.A., Kotenko S.V., Pestka S., Stark G.R., Ihle J.N., and Kerr I.M. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol. Cell. Biol. 17 (1997) 695-706
21. Smart E.J., Ying Y.S., Mineo C., and Anderson R.G. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc. Natl. Acad. Sci. USA 92 (1995) 10104-10108
22. He K., Loesch K., Cowan J.W., Li X., Deng L., Wang X., Jiang J., and Frank S.J. JAK2 enhances the stability of the mature GH receptor. Endocrinology 145 (2005) 4755-4765
23. Asa S.L., Digiovanni R., Jiang J., Ward M.L., Loesch K., Yamada S., Sano T., Yoshimoto K., Frank S.J., and Ezzat S. A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors. Cancer Res. 67 (2007) 7505-7511
24. Barman S., Adhikary L., chakrabarti A.K., Bernas C., Kawaoka Y., and Nayak D.P. Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding. J. Virol. 78 (2004) 5258-5269
25. Gosse J.A., Wagenknecht-Wiesner A., Holowka D., and Baird B. Transmembrane sequences are determinants of immunoreceptor signaling. J. Immunol. 175 (2005) 2123-2131
26. Bock J., and Gulbins E. The transmembranous domain of CD40 determines CD40 partitioning into lipid rafts. FEBS Lett. 534 (2003) 169-174
27. Perschl A., Lesley J., English N., Hyman R., and Trowbridge I.S. Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts. J. Cell Sci. 108 Pt. 3 (1995) 1033-1041
28. Yasui T., Luftig M., Soni V., and Kieff E. Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling. Proc. Natl. Acad. Sci. USA 101 (2004) 278-283
29. Yamabhai M., and Anderson R.G. Second cysteine-rich region of epidermal growth factor receptor contains targeting information for caveolae/rafts. J. Biol. Chem. 277 (2002) 24843-24846
30. Yang H., and Reinherz E.L. Dynamic recruitment of human CD2 into lipid rafts. Linkage to T cell signal transduction. J. Biol. Chem. 276 (2001) 18775-18785
31. Popik W., and Alce T.M. CD4 receptor localized to non-raft membrane microdomains supports HIV-1 entry. Identification of a novel raft localization marker in CD4. J. Biol. Chem. 279 (2004) 704-712
32. 2+-sensitive adenylyl cyclases dictate their targeting to plasma membrane lipid rafts. J. Biol. Chem. 280 (2005) 6380-6391
33. Goebel J., Forrest K., Morford L., and Roszman T.L. Differential localization of IL-2- and -15 receptor chains in membrane rafts of human T cells. J. Leukoc. Biol. 72 (2002) 199-206
34. Takaoka A., Mitani Y., Suemori H., Sato M., Yokochi T., Noguchi S., Tanaka N., and Taniguchi T. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science 288 (2000) 2357-2360
35. Kondadasula S.V., Roda J.M., Parihar R., Yu J., Lehman A., Caligiuri M.A., Tridandapani S., Burry R.W., and Carson III W.E. Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma. Blood 111 (2008) 4173-4183
36. Kim J., Adam R.M., Solomon K.R., and Freeman M.R. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells. Endocrinology 145 (2004) 613-619
37. de Vos A.M., Ultsch M., and Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255 (1992) 306-312
38. Jiang J., Wang X., He K., Li X., Chen C., Sayeski P.P., Waters M.J., and Frank S.J. A conformationally-sensitive GHR (growth hormone (GH) receptor) antibody: impact on GH signaling and GHR proteolysis. Mol. Endocrinol. 18 (2004) 2981-2996
39. Harding P.A., Wang X.Z., Kelder B., Souza S., Okada S., and Kopchick J.J. In vitro mutagenesis of growth hormone receptor Asn-linked glycosylation sites. Mol. Cell. Endocrinol. 106 (1994) 171-180
40. Rowlinson S.W., Barnard R., Bastiras S., Robins A.J., Brinkworth R., and Waters M.J. A growth hormone agonist produced by targeted mutagenesis at binding site 1. Evidence that site 1 regulates bioactivity. J. Biol. Chem. 270 (1995) 16833-16839
41. Chen C., Brinkworth R., and Waters M.J. The role of receptor dimerization domain residues in growth hormone signaling. J. Biol. Chem. 272 (1997) 5133-5140